PortfoliosLab logoPortfoliosLab logo
NVDA vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NVDA vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NVIDIA Corporation (NVDA) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NVDA achieves a 10.16% return, which is significantly lower than TGTX's 66.12% return. Over the past 10 years, NVDA has outperformed TGTX with an annualized return of 67.95%, while TGTX has yielded a comparatively lower 21.61% annualized return.


NVDA

1D
0.16%
1M
-9.03%
YTD
10.16%
6M
17.38%
1Y
41.70%
3Y*
71.13%
5Y*
63.13%
10Y*
67.95%

TGTX

1D
3.06%
1M
16.11%
YTD
66.12%
6M
57.96%
1Y
32.51%
3Y*
21.69%
5Y*
5.57%
10Y*
21.61%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NVDA vs. TGTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NVDA
NVIDIA Corporation
10.16%38.92%171.25%239.02%-50.26%125.48%122.30%76.94%-30.82%81.99%
TGTX
TG Therapeutics, Inc.
66.12%-0.96%76.23%44.38%-37.74%-63.48%368.65%170.73%-50.00%76.34%

Correlation

The correlation between NVDA and TGTX is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.30

Correlation (All Time)
Calculated using the full available price history since May 3, 2010

0.23

The correlation between NVDA and TGTX shifts across timeframes, from 0.03 (1 year) to 0.30 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NVDA:

$5.00T

TGTX:

$7.93B

EPS

NVDA:

$6.53

TGTX:

$2.87

PE Ratio

NVDA:

31.44

TGTX:

17.23

PEG Ratio

NVDA:

0.17

TGTX:

0.03

PS Ratio

NVDA:

19.80

TGTX:

11.37

PB Ratio

NVDA:

25.60

TGTX:

13.59

Total Revenue (TTM)

NVDA:

$253.49B

TGTX:

$700.35M

Gross Profit (TTM)

NVDA:

$187.95B

TGTX:

$581.54M

EBITDA (TTM)

NVDA:

$192.76B

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NVDA vs. TGTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVDA
NVDA Risk / Return Rank: 7575
Overall Rank
NVDA Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
NVDA Sortino Ratio Rank: 7373
Sortino Ratio Rank
NVDA Omega Ratio Rank: 7171
Omega Ratio Rank
NVDA Calmar Ratio Rank: 7777
Calmar Ratio Rank
NVDA Martin Ratio Rank: 7777
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 6363
Overall Rank
TGTX Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 6464
Sortino Ratio Rank
TGTX Omega Ratio Rank: 6363
Omega Ratio Rank
TGTX Calmar Ratio Rank: 6464
Calmar Ratio Rank
TGTX Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVDA vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NVIDIA Corporation (NVDA) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NVDATGTXDifference
Sharpe ratioReturn per unit of total volatility

+0.51

Sortino ratioReturn per unit of downside risk

+0.46

Omega ratioGain probability vs. loss probability

1.21

1.16

+0.05

Calmar ratioReturn relative to maximum drawdown

2.07

1.00

+1.07

Martin ratioReturn relative to average drawdown

4.94

1.81

+3.13

NVDA vs. TGTX - Sharpe Ratio Comparison

The current NVDA Sharpe Ratio is 1.20, which is higher than the TGTX Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of NVDA and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NVDA vs. TGTX - Drawdown Comparison

The maximum NVDA drawdown since its inception was -89.72%, smaller than the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for NVDA and TGTX.


Loading charts...

Drawdown Indicators


NVDATGTXDifference

Max Drawdown

Largest peak-to-trough decline

-89.72%

-99.52%

+9.80%

Max Drawdown (1Y)

Largest decline over 1 year

-20.21%

-32.66%

+12.45%

Max Drawdown (3Y)

Largest decline over 3 years

-36.88%

-75.42%

+38.54%

Max Drawdown (5Y)

Largest decline over 5 years

-66.34%

-90.75%

+24.41%

Max Drawdown (10Y)

Largest decline over 10 years

-66.34%

-93.19%

+26.85%

Current Drawdown

Current decline from peak

-12.86%

-78.79%

+65.93%

Average Drawdown

Average peak-to-trough decline

-36.18%

-91.43%

+55.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.46%

18.04%

-9.58%

Volatility

NVDA vs. TGTX - Volatility Comparison

The current volatility for NVIDIA Corporation (NVDA) is 13.26%, while TG Therapeutics, Inc. (TGTX) has a volatility of 15.65%. This indicates that NVDA experiences smaller price fluctuations and is considered to be less risky than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NVDATGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.26%

15.65%

-2.39%

Volatility (6M)

Calculated over the trailing 6-month period

26.67%

34.28%

-7.61%

Volatility (1Y)

Calculated over the trailing 1-year period

35.00%

47.22%

-12.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.76%

87.77%

-36.01%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.84%

86.88%

-37.04%

Dividends

NVDA vs. TGTX - Dividend Comparison

NVDA's dividend yield for the trailing twelve months is around 0.14%, while TGTX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
NVDA
NVIDIA Corporation
0.14%0.02%0.03%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%
TGTX
TG Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

NVDA vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between NVIDIA Corporation and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20222023202420252026
81.62B
204.92M
(NVDA) Total Revenue
(TGTX) Total Revenue
Values in USD except per share items

NVDA vs. TGTX - Profitability Comparison

The chart below illustrates the profitability comparison between NVIDIA Corporation and TG Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%100.0%20222023202420252026
74.9%
83.7%
Portfolio components
NVDA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a gross profit of 61.16B and revenue of 81.62B. Therefore, the gross margin over that period was 74.9%.

TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

NVDA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported an operating income of 53.54B and revenue of 81.62B, resulting in an operating margin of 65.6%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

NVDA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NVIDIA Corporation reported a net income of 58.32B and revenue of 81.62B, resulting in a net margin of 71.5%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.


Frequently Asked Questions


NVDA and TGTX have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TGTX has higher volatility (15.65%) compared to NVDA (13.26%). In terms of maximum drawdown, NVDA dropped -89.72% vs TGTX's -99.52%.

NVDA currently has the higher Sharpe Ratio (1.20 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NVDA and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer